Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CanISleepinMS Study of cannabidiol for insomnia in multiple sclerosis
NL-OMON60588Phase 2Completed
- Sponsor
- Wageningen Research
- Start
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in Insomnia, sponsored by Wageningen Research. Primary endpoint: Insomnia Severity Index. Started Mar 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
Insomnia
Beyond the preview
Go deeper on NL-OMON60588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60588.